Don O’Sullivan

Don O’Sullivan currently serves as the Chief Business Officer at AsherBio, attracted to the role by the company’s dedicated team and the chance to advance Asher’s innovative cis-targeted immunotherapies. Before joining AsherBio, he was the Vice President and Global Head of Oncology Partnering at Roche and Genentech, where he also held various significant roles over nearly 12 years, including leading the partnering efforts for Genentech’s Immunology and Infectious Disease R&D groups. Prior to his tenure at Genentech, O’Sullivan spent three years in the Corporate Development group at Genzyme. He holds a Ph.D. in Molecular Biology from the University of Cambridge, an MBA from Wharton, University of Pennsylvania, and a B.Sc. in Biochemistry from Imperial College, London, underscoring his deep scientific and strategic business expertise in the biotechnology field.